Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US. Abzena’s complimentary services and technologies in chemistry, biology and manufacturing, are applied to the selection, development and manufacture of better biopharmaceuticals.. . Abzena works with most of the top 20 biopharmaceutical companies and academic groups around the world, and has enabled many of them to progress products (ABZENA inside), through to clinical development. Abzena’s teams at the Babraham Research Campus, Cambridge, UK and in San Diego, CA and Bristol, PA in the US are focused on developing better treatments for patients.
Actigen focuses on the development of novel biotherapeutics, specifically antibodies and protein-based drugs. . . Operating globally from its base in Cambridge, UK, Actigen is working with an expanding network of academic, scientific and medical experts to progress a number of development projects.
Agenus, Inc. https://www.agenusbio.com is an immuno-oncology company focused on the discovery and development of revolutionary new treatments that engage the body's immune system to benefit cancer patients. By combining multiple powerful platforms, Agenus has established a highly integrated approach for the discovery, development and manufacture of monoclonal antibodies that modulate targets of interest. In addition, Agenus' cancer vaccine programme includes three proprietary platforms focused on individualised and off-the-shelf vaccines uniquely designed for each patient. Agenus' broad portfolio of novel checkpoint and other immuno-modulatory monoclonal antibodies, vaccines and adjuvants work in combination to provide the opportunity to create best-in-class therapeutic regimens.
We support our Clients by navigating through technical challenges, translating data into strategy and communication, and revealing the impact of their science.
Air Liquide UK Limited, part of the world leading Air Liquide Group, provides your single source of expertise for the full range of industrial, laboratory and medical gases and related technologies. We are the preferred supplier for all laboratory gases, with attractive pricing for all Gold members of One Nucleus. Air Liquide UK also offers: specialty gases in cylinders, pressure cans and lecture bottles; dry ice (Cardice®); industrial gases in cylinders; bulk carbon dioxide, air gases (nitrogen, oxygen and argon), and engineering support services.
Air Products is a market leader in the life science sector and is the only industrial gas company manufacturing liquid nitrogen in the UK that is compliant to the new Medical Device Regulation. As a preferred supplier to One Nucleus, members are entitled to preferential pricing on our standard products, please contact for details. Air Products enables customers across numerous industries to improve their environmental performance, product quality and productivity. We are not only experts in speciality gases but are also uniquely placed to offer a total solution for cryogenic freezing; With our extensive knowledge in the production and safe handling of liquid nitrogen, coupled with our class-leading range of MVE freezers. Whether you store on a small scale or if you need a complete cryogenic lab project managed, we provide a complete solution offering as much or as little as your business needs.
No data available
No data available
No data available
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners across academia, biotech, and the largest biopharma, Alloy democratizes access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics across six modalities: antibodies, TCRs, genetic medicines, cell therapies, peptides, and drug delivery. Partners may access all current and future technologies through a discovery service relationship or for a flat annual fee through Alloy’s Innovation Subscriptions offering. As a reflection of Alloy’s relentless commitment to the scientific community, Alloy reinvests 100% of its revenue in innovation and access to innovation. Alloy is headquartered in Boston, MA, with labs in Cambridge, UK; Basel, CH; San Francisco, CA; and Athens, GA. To learn how to collaborate with Alloy, connect with us at: alloytx.com/contact